Document is current
Any future updates will be listed below
-
Authors
Savchuk, Solomiia
Gentry, Kaylee M.
Wang, Wengang https://orcid.org/0000-0002-4659-6909
Carleton, Elana
Biagi-Junior, Carlos A. O. https://orcid.org/0000-0003-0700-3135
Luthria, Karan https://orcid.org/0000-0002-4392-9675
Yalçın, Belgin https://orcid.org/0000-0001-9689-9062
Ni, Lijun
Farnsworth, Hannah C.
Davis, Rachel A.
Drexler, Richard
Melms, Johannes C. https://orcid.org/0000-0002-5410-6586
Liu, Yin https://orcid.org/0000-0002-2377-2703
Acosta-Alvarez, Lehi https://orcid.org/0000-0002-2890-4947
Hartmann, Griffin G. https://orcid.org/0000-0001-9213-8995
Pavarino, Elisa C.
LaBelle, Jenna
Woo, Pamelyn J.
Toland, Angus M.
Qu, Fangfei
Kim, Yoon Seok
Filbin, Mariella G.
Krasnow, Mark A. https://orcid.org/0000-0002-1976-5471
Ligon, Keith L. https://orcid.org/0000-0002-7733-600X
Izar, Benjamin https://orcid.org/0000-0003-2379-6702
Sage, Julien https://orcid.org/0000-0002-8928-9968
Sabatini, Bernardo L. https://orcid.org/0000-0003-0095-9177
Monje, Michelle https://orcid.org/0000-0002-3547-237X
Venkatesh, Humsa S. https://orcid.org/0000-0003-1194-3015
- License Information
-
More Information
Article History
Received: 2 December 2022
Accepted: 4 August 2025
First Online: 10 September 2025
Competing interests
: M.M. holds equity in MapLight Therapeutics and Stellaromics, and stock in CARGO Therapeutics. M.M. was previously on the scientific advisory board for Cygnal Therapeutics. J.S. has equity in and is an advisor for DISCO Pharmaceuticals. B.I. has received consulting fees and honoraria from Volastra Therapeutics Inc., Merck, AstraZeneca, Novartis, Eisai and Janssen Pharmaceuticals and has received research funding to Columbia University from Alkermes, Arcus Biosciences, Checkmate Pharmaceuticals, Compugen, Immunocore, Merck, Regeneron and Synthekine. B.I. is a founder of Basima Therapeutics, Inc.
